Tripartite motif protein 25 is associated with epirubicin resistance in hepatocellular carcinoma cells via regulating PTEN/AKT pathway
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tripartite motif protein 25 is associated with epirubicin resistance in hepatocellular carcinoma cells via regulating PTEN/AKT pathway
Authors
Keywords
-
Journal
CELL BIOLOGY INTERNATIONAL
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-03-21
DOI
10.1002/cbin.11346
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Blockade of miR-3614 maturation by IGF2BP3 increases TRIM25 expression and promotes breast cancer cell proliferation
- (2019) Zhenzhen Wang et al. EBioMedicine
- The impact of phosphatases on proliferative and survival signaling in cancer
- (2018) Goutham Narla et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- The E3 ligase for metastasis associated 1 protein, TRIM25, is targeted by microRNA-873 in hepatocellular carcinoma
- (2018) Yu-Hui Li et al. EXPERIMENTAL CELL RESEARCH
- Efficacy and safety of epirubicin applied in transcatheter arterial chemoembolization for hepatocellular carcinoma: A meta-analysis
- (2018) Zhibin Bai et al. Journal of Cancer Research and Therapeutics
- TRIM25 enhances cell growth and cell survival by modulating p53 signals via interaction with G3BP2 in prostate cancer
- (2018) Ken-ichi Takayama et al. ONCOGENE
- Oncogenic TRIM31 confers gemcitabine resistance in pancreatic cancer via activating the NF-κB signaling pathway
- (2018) Chao Yu et al. Theranostics
- TRIM32 promotes proliferation and confers chemoresistance to breast cancer cells through activation of the NF-κB pathway
- (2018) Ting-Ting Zhao et al. Journal of Cancer
- The ubiquitin ligase TRIM25 inhibits hepatocellular carcinoma progression by targeting metastasis associated 1 protein
- (2017) Hong-liang Zang et al. IUBMB LIFE
- Nanomedicine to Deal With Cancer Cell Biology in Multi-Drug Resistance
- (2017) Pawan Tekchandani et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- TRIM59 facilitates the proliferation of colorectal cancer and promotes metastasis via the PI3K/AKT pathway
- (2017) Ye Sun et al. ONCOLOGY REPORTS
- TRIM Family Proteins: Roles in Autophagy, Immunity, and Carcinogenesis
- (2017) Shigetsugu Hatakeyama TRENDS IN BIOCHEMICAL SCIENCES
- miR-182 promotes tumor growth and increases chemoresistance of human anaplastic thyroid cancer by targeting tripartite motif 8
- (2017) Yao Liu et al. OncoTargets and Therapy
- An Integrated Systems Biology Approach Identifies TRIM25 as a Key Determinant of Breast Cancer Metastasis
- (2017) Logan A. Walsh et al. Cell Reports
- UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
- (2017) Darshan S. Chandrashekar et al. NEOPLASIA
- TRIM14 regulates cell proliferation and invasion in osteosarcoma via promotion of the AKT signaling pathway
- (2017) Guoxing Xu et al. Scientific Reports
- Overexpression of TRIM25 in Lung Cancer Regulates Tumor Cell Progression
- (2016) Ying Qin et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- TRIM25 blockade by RNA interference inhibited migration and invasion of gastric cancer cells through TGF-β signaling
- (2016) Zhenya Zhu et al. Scientific Reports
- The BCL-2 protein family, BH3-mimetics and cancer therapy
- (2015) A R D Delbridge et al. CELL DEATH AND DIFFERENTIATION
- HES5 promotes cell proliferation and invasion through activation of STAT3 and predicts poor survival in hepatocellular carcinoma
- (2015) Guizhou Zhu et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Treatment of intermediate-stage hepatocellular carcinoma
- (2014) Alejandro Forner et al. Nature Reviews Clinical Oncology
- TRIM24 promotes glioma progression and enhances chemoresistance through activation of the PI3K/Akt signaling pathway
- (2014) L-H Zhang et al. ONCOGENE
- Targeting the Akt Kinase to Modulate Survival, Invasiveness and Drug Resistance of Cancer Cells
- (2013) Giuliana Cassinelli et al. CURRENT MEDICINAL CHEMISTRY
- Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
- (2012) Oktay Tacar et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- p53-Independent up-regulation of a TRAIL receptor DR5 by proteasome inhibitors: A mechanism for proteasome inhibitor-enhanced TRAIL-induced apoptosis
- (2011) Dai-Wu Seol BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Lupeol targets liver tumor-initiating cells through phosphatase and tensin homolog modulation
- (2010) Terence Kin Wah Lee et al. HEPATOLOGY
- Chemotherapy for advanced hepatocellular carcinoma
- (2008) Kwang-Hyub Han et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More